Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Nov 16, 2010

Premium

BioDiscovery last week released version 5.1 of its Nexus Copy Number software for DNA copy number analysis.

The upgrade includes the addition of the FASST2 segmentation algorithm, incorporation of PennCNV processing, and support for Affymetrix OncoScan arrays.

Additionally, BioDiscovery said it has improved the tool's interface to allow users to more easily identify possible pathogenic regions, compare those with already processed samples, obtain annotations from many external databases, and generate customized reports.

BioDiscovery claims its tool can integrate and process together, in a single project, data from most commercially available array platforms. The software tool is applicable in cytogenetics research and genome-wide association studies, according to the firm.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.